D.A. Wallach Explains Why Biotech VC Is So Different | Odd Lots
Most people think of venture capital as funding software startups or, these days, some new AI tool. But VC also plays a major role in developing new medicines and treatments. That’s the world of D.A. Wallach — though he didn’t start there. Before becoming a biotech investor, Wallach was the lead singer of the indie rock band Chester French. So how did he make the leap from music to venture capital? How does he spot promising biotech opportunities? What does it actually take to bring a new drug to market? And how does biotech investing differ from traditional VC? We talk to the co-founder of Time BioVentures about all of this — plus we get his thoughts on AI’s impact on music and a special performance. Introduction [0:00] Guest Introduction [2:27] Biotech Investment Fundamentals [5:37] Deal Sourcing and Market Dynamics [8:32] Industry Characteristics and "Tech Bio" Movement [11:18] AI in Drug Discovery [16:09] Clinical Trial Bottlenecks and Regulatory Issues [18:37] China Competition and Global Dynamics [24:23] Public Market Biotech Investing [26:56] Recent Biotech Downturn [29:23] US Drug Pricing and Global Markets [31:30] Political Environment and Public Trust [33:50] Healthcare System Autonomy and Insurance [37:52] Music, AI, and Creative Expression [39:32] New "Odd Lots theme song” [44:04] Closing remarks [45:31] #Biotech #VC #OddLots Join the conversation: discord.gg/oddlots Subscribe to Bloomberg Podcasts: https://bit.ly/BloombergPodcasts Check out more Odd Lots: • Odd Lots (Audio) Get the Odd Lots newsletter via https://www.bloomberg.com/account/new... And for all things Odd Lots, visit https://www.bloomberg.com/oddlots Bloomberg's Joe Weisenthal and Tracy Alloway analyze the weird patterns, the complex issues and the newest market crazes. Join the conversation every Monday and Thursday for interviews with the most interesting minds in finance, economics and markets. #OddLots #Markets #Investing #Business #Finance #Podcast Visit us: https://www.bloomberg.com/podcasts For coverage on news, markets and more: http://www.bloomberg.com/video

MeatEater's Steven Rinella on the Economic History of Hunting | Odd Lots

Is It a Bubble?

LA mayor's race: Bass maintains lead as Raman closes gap with Pratt

What VCs Look for When Investing in Bio and Healthcare

Why Paul Kedrosky Says AI Is Like Every Bubble All Rolled Into One | Odd Lots

Why Ben Horowitz Says the Classic VC Model Is Over

Professor Jiang: World War 3 Is About To Begin, Let Me Explain!

Culture, with Dr David Vik

How Do I Prepare for a Venture Capital Interview | Venture Capitalist Explains

The Hardest Problem AI Ever Solved, with Google DeepMind CEO

This Is What It Takes to Get a Data Center Financed | Odd Lots

Aswath Damodaran: The AI Boom Is Headed For A Reckoning

How to Build a Remarkable Brand in the Age of AI | Seth Godin

Something is jamming GPS over Europe. Here's what we found

How To Get A Job In Venture Capital (From a Former VC!)

Anthropic C.E.O.: Massive A.I. Spending Could Haunt Some Companies

The Utilities Analyst Who Says The Data Center Demand Story Doesn't Add Up | Odd Lots

Zohran Mamdani says Iran war speaks to a “broken kind of politics” | Newsmakers

Venture Capital Perspectives: Early Stage Biotech Investing with Doug Cole, Flagship Ventures

